Fadd and Skp2 are possible downstream targets of RUNX1-EVI1

Kazuhiro Maki1, Fusako Sugita, Yuka Nakamura

  • 1Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, Japan.

Insights

The RUNX1-EVI1 fusion gene drives leukemia by blocking myeloid cell differentiation and preventing apoptosis. Histone deacetylase inhibitors reverse these effects, identifying key target genes involved in leukemogenesis.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • The RUNX1-EVI1 fusion gene, resulting from t(3;21), is implicated in the leukemic transformation of chronic hematopoietic stem cell disorders.
  • RUNX1-EVI1 dysregulates target genes by recruiting histone deacetylase (HDAC) via carboxyl terminal-binding protein, inhibiting myeloid precursor cell differentiation and apoptosis.

Purpose of the Study:

  • To investigate the role of RUNX1-EVI1 in myeloid cell transformation using mouse primary hematopoietic cells.
  • To identify specific genes targeted by RUNX1-EVI1 that contribute to leukemogenesis.

Main Methods:

  • Primary mouse hematopoietic cells were engineered to express RUNX1-EVI1.
  • Cells were treated with granulocyte colony-stimulating factor (G-CSF) and/or HDAC inhibitors (trichostatin A, valproic acid).
  • Gene expression profiling focused on apoptosis and cell-cycle-related genes.

Main Results:

  • RUNX1-EVI1 expression enhanced replating activity and repressed myeloid differentiation under G-CSF stimulation.
  • HDAC inhibitors reversed the differentiation block and apoptotic prevention induced by RUNX1-EVI1.
  • Expression of Fadd, Skp2, and CD40lg was suppressed by RUNX1-EVI1 and restored by HDAC inhibitors, suggesting they are targets.

Conclusions:

  • RUNX1-EVI1-mediated leukemogenesis involves HDAC recruitment and transcriptional repression of key genes like Fadd, Skp2, and CD40lg.
  • HDAC inhibitors hold potential for therapeutic intervention in RUNX1-EVI1-driven leukemias.
  • These identified genes may be direct or indirect targets critical for RUNX1-EVI1's oncogenic activity.

Related Concept Videos

Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...